Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 2 (February)

1. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.
   Surgery, 139(2): 188-96. [Abstract] [Full-text]
2. Necrolytic migratory erythema.
   J Cutan Pathol, 33(3): 242-5. [Abstract] [Full-text]
3. Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells.
   Int J Cancer, 118(8): 1930-6. [Abstract] [Full-text]
4. Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study.
   Br J Cancer, 94(4): 481-5. [Abstract] [Full-text]
5. In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer.
   Int J Cancer, 118(9): 2337-43. [Abstract] [Full-text]
6. The clinical significance of MAGEA3 expression in pancreatic cancer.
   Int J Cancer, 118(9): 2269-75. [Abstract] [Full-text]
7. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
   J Clin Oncol, 24(7): 1145-51. [Abstract] [Full-text]
8. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.
   Cancer Immunol Immunother, 55(6): 684-98. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.